Apollo, by Ordaos (https://ordaos.bio), is an ML-driven drug design platform used to discover life-saving medicines 100x faster than alternative methods. Researchers provide their ideal drug profile to Apollo whose generative AI and in silico assays design optimal mini-protein therapeutics within just days.
Location: United States, South Dakota
Employees: 11-50
Founded date: 2019
Investors 5
| Date | Name | Website |
| 26.10.2023 | SeedFolio | seedfolio.... |
| - | Route 66 V... | r66.vc |
| 30.06.2022 | Route 66 V... | route66ven... |
| 09.12.2020 | Future Lab... | futurelabs... |
| - | StartX | startx.com |
Mentions in press and media 2
| Date | Title | Description |
| 01.06.2023 | Ordaōs Selected to Participate in the AWS Generative AI Accelerator | Ordaōs, a human-enabled, machine-driven drug design company that creates novel and customized mini-proteins, announced it has been selected to participate in the inaugural cohort of the AWS Generative AI Accelerator, a technical, business, ... |
| 26.08.2022 | Ordaōs Raises $5M in Seed Funding | Ordaōs, a New York-based biotechnology company designing mini-proteins to help drug hunters deliver life-saving treatments, raised $5M in Seed funding. The round was led by Middleland Capital’s VTC Ventures with participation from Route 66 ... |